Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,659.80
-17.40 (-0.65%)
Nov 12, 2026, 3:29 PM IST
Glenmark Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Glenmark Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹2,660. The average 1-year stock price forecast is 0.01% lower than the current stock price, while the lowest is ₹2,100 (-21.05%) and the highest is ₹3,069 (+15.38%).
Price Target: ₹2,660 (-0.01%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Glenmark Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 6 |
| Buy | 3 | 4 | 3 | 3 | 3 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
171.00B
from 170.43B
Increased by 0.34%
Revenue Next Year
189.22B
from 171.00B
Increased by 10.65%
EPS This Year
73.77
from 103.32
Decreased by -28.60%
EPS Next Year
95.48
from 73.77
Increased by 29.42%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.